Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Free Radic Res ; 49(5): 681-91, 2015 May.
Article in English | MEDLINE | ID: mdl-25740198

ABSTRACT

Exposure to rotenone in vivo results in selective degeneration of dopaminergic neurons and development of neuropathologic features of Parkinson's disease (PD). As rotenone acts as an inhibitor of mitochondrial respiratory complex I, we employed oxidative lipidomics to assess oxidative metabolism of a mitochondria-specific phospholipid, cardiolipin (CL), in substantia nigra (SN) of exposed animals. We found a significant reduction in oxidizable polyunsaturated fatty acid (PUFA)-containing CL molecular species. We further revealed increased contents of mono-oxygenated CL species at late stages of the exposure. Notably, linoleic acid in sn-1 position was the major oxidation substrate yielding its mono-hydroxy- and epoxy-derivatives whereas more readily "oxidizable" fatty acid residues (arachidonic and docosahexaenoic acids) remained non-oxidized. Elevated levels of PUFA CLs were detected in plasma of rats exposed to rotenone. Characterization of oxidatively modified CL molecular species in SN and detection of PUFA-containing CL species in plasma may contribute to better understanding of the PD pathogenesis and lead to the development of new biomarkers of mitochondrial dysfunction associated with this disease.


Subject(s)
Cardiolipins/metabolism , Chromatography, High Pressure Liquid , Mass Spectrometry , Mitochondria/metabolism , Parkinsonian Disorders/metabolism , Rotenone , Substantia Nigra/metabolism , Animals , Arachidonic Acid/metabolism , Biomarkers/metabolism , Cardiolipins/blood , Disease Models, Animal , Docosahexaenoic Acids/metabolism , Linoleic Acid/metabolism , Male , Oxidation-Reduction , Parkinsonian Disorders/blood , Parkinsonian Disorders/chemically induced , Rats, Inbred Lew , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...